PNG Vaccination Rates: Barriers to Immunization in East New Britain 2023

Four in ten children in Papua Latest Guinea’s East New Britain Province (ENBP) didn’t receive essential vaccinations in 2023, a figure raising concerns about ongoing public health vulnerabilities. While caregivers generally support immunization, new research illuminates the significant practical obstacles preventing families from accessing these life-saving interventions. The study, conducted by the Burnet Institute, points to issues like the cost of travel to clinics, the sheer distance families must cover, and intermittent vaccine availability as key barriers.

Understanding Immunization Coverage in East New Britain

Papua New Guinea faces substantial challenges in achieving widespread immunization coverage. According to data from 2023, an estimated 59% of people in East New Britain were considered ‘zero-dose,’ meaning they hadn’t received even a single dose of the Diphtheria-Tetanus-Pertussis (DTP) vaccine. DTP protects against three serious bacterial infections: diphtheria, tetanus (lockjaw), and pertussis (whooping cough). These diseases can be particularly dangerous for infants and young children, potentially leading to severe complications or even death. Burnet Institute’s work focuses on addressing these gaps in coverage.

The Burnet Institute’s research didn’t simply identify the problem. it delved into the reasons behind it. Researchers engaged directly with local communities in East New Britain, speaking with caregivers, healthcare workers, and community and religious leaders. They employed a mixed-methods approach, utilizing surveys, in-depth interviews, and focus groups. Crucially, they similarly leveraged tools developed by the World Health Organization (WHO), specifically the Behavioural and Social Drivers (BeSD) of Vaccination, to gain a nuanced understanding of the factors influencing immunization decisions.

What the Research Methods Reveal

The BeSD framework is designed to move beyond simply asking if people are vaccinated, and instead explore why or why not. It considers a wide range of influences, including psychological, social, economic, and environmental factors. This approach is vital since vaccination isn’t purely a medical issue; it’s deeply intertwined with people’s beliefs, experiences, and circumstances. The Burnet Institute’s use of this framework suggests a commitment to understanding the root causes of low immunization rates, rather than simply treating the symptoms.

The study’s findings highlight that while there isn’t widespread opposition to vaccination itself, logistical and financial hurdles are preventing many families from accessing the services. Travel costs, particularly in a geographically challenging province like East New Britain, can be prohibitive. Distance to clinics adds to the burden, especially for families in remote areas. Inconsistent vaccine supply can mean that even when families are willing and able to travel, the vaccines aren’t available.

Papua New Guinea’s Broader Health Landscape

Papua New Guinea faces significant health challenges beyond immunization rates. The country has one of the highest maternal mortality rates globally. Burnet Institute is actively involved in initiatives aimed at improving maternal and newborn health, recognizing that these issues are interconnected. Strengthening the overall health system, including infrastructure and workforce capacity, is crucial for addressing a range of health priorities.

Burnet Institute’s long-term engagement in PNG, spanning several decades, demonstrates a commitment to building sustainable partnerships. Their work extends beyond specific projects to encompass broader efforts to improve governance, health surveillance, and workforce development. This holistic approach is essential for creating lasting positive change.

Antimicrobial Resistance and Other Health Priorities

Alongside immunization and maternal health, Burnet Institute is also tackling other critical health issues in PNG, such as antimicrobial resistance (AMR). They are leading the PNG Country Grant component of the Fleming Fund, a UK Aid program dedicated to combating AMR in low- and middle-income countries. AMR occurs when microorganisms like bacteria develop resistance to the drugs used to treat infections, making infections harder to treat and increasing the risk of disease spread. Further details on Burnet’s work in PNG can be found on their website.

What Comes Next: Addressing the Barriers to Vaccination

The Burnet Institute’s research is not an finish in itself, but rather a crucial step towards developing effective strategies to increase immunization coverage in East New Britain. The project aims to identify under-immunized children, pinpoint the challenges and opportunities related to childhood vaccination, and ultimately implement strategies to overcome these obstacles. The collaboration with the East New Britain Provincial Health Authority (ENBPHA) is key to ensuring that the findings are translated into practical action.

The analysis of the data collected through surveys, interviews, and focus groups will inform the development of targeted interventions. These interventions might include strategies to reduce travel costs, improve vaccine supply chain management, or address community-specific concerns about vaccination. The success of these efforts will depend on continued collaboration between researchers, healthcare providers, and local communities.

Further research is needed to assess the long-term impact of these interventions and to identify any emerging challenges. Ongoing surveillance of immunization rates will be essential to monitor progress and ensure that no child is left behind. The Burnet Institute’s work serves as a valuable model for other regions facing similar challenges in achieving universal immunization coverage.